SOLIGENIX receives positive EMA opinion for SGX945 orphan drug designation Feb 26, 2026 07:32AM
Soligenix provides update on late-stage rare disease pipeline Feb 12, 2026 07:31AM
Soligenix enters agreement to sell up to $3.45 million in stock Jan 23, 2026 04:09PM
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event Jan 23, 2026 02:50PM
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event Jan 23, 2026 02:50PM


Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Nov 7, 2025 04:25PM Soligenix, Inc. (SNGX) Misses Q3 EPS by 58c
Oct 8, 2025 07:00AM Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates
Sep 23, 2025 07:30AM Soligenix names former White House adviser Philipson as strategic advisor
Sep 4, 2025 07:31AM Soligenix vaccine study shows 2-year stability at high temperatures
Aug 14, 2025 04:14PM Soligenix, Inc. (SNGX) Misses Q2 EPS by 82c
Aug 7, 2025 08:31AM Soligenix featured in editorial on rare disease therapy development
Jul 1, 2025 07:30AM Soligenix (SNGX) Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
May 9, 2025 04:59PM Soligenix, Inc. (SNGX) Misses Q4 EPS by 106c
Apr 24, 2025 10:41AM Soligenix, Inc. (SNGX) HyBryte shows 75% response rate in trial
Mar 25, 2025 07:32AM Soligenix, Inc. (SNGX) Announces Publication Demonstrating CiVax Booster Induces Rapid Broad Protection Against COVID-19 Variants
Mar 21, 2025 07:31AM Soligenix (SNGX) Provides Update on Recent Accomplishments, Reports FY24 Results
Nov 27, 2024 07:00AM DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Nov 27, 2024 07:00AM DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Nov 19, 2024 07:30AM Soligenix (SNGX) Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
Nov 15, 2024 07:30AM Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Nov 8, 2024 07:50AM Soligenix, Inc. (SNGX) Misses Q3 EPS by 78c
Oct 22, 2024 07:31AM Soligenix (SNGX) Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
Oct 3, 2024 07:30AM Soligenix (SNGX) Announces Partnership with Sterling Pharma Solutions
Sep 20, 2024 09:00AM Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Sep 3, 2024 07:31AM Soligenix (SNGX) Receives European Patent for Improved Production of Synthetic Hypericin
Aug 16, 2024 09:00AM Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 9, 2024 08:21AM Soligenix(SNGX): Expanded HyBryte Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Jun 25, 2024 07:31AM Soligenix (SNGX) Announces Positive Results from a Comparative Study of HyBryte Against Valchlor